HBO has officially greenlit a sophomore season of drama “In Treatment.”
Series stars Gabriel Byrne as psychotherapist Paul Weston and revolves entirely around his sessions with patients and his own therapy appointments with shrink Gina Toll, played by Dianne Wiest. HBO had been widely expected to greenlight a second season of the show, but it took some time for the paybox to cut a fresh pact with Byrne, biz insiders said.
“In Treatment,” based on an Israeli TV skein of the same name (“BeTipul” in Hebrew), bowed on HBO in January as an adventurous experiment in programming 43 segs as a half-hour drama strip Monday-Friday. The skedding pattern will likely be tweaked for the second season given that ratings for the Monday-Friday premiere telecasts were not too strong. HBO is expected to order some 35 episodes for season two.
“In Treatment” is also due for a fresh influx of supporting cast members, as most of Weston’s patients from season one will not be returning other than possibly for brief appearances in a handful of episodes. An HBO rep said deals with new and potential returning cast members were still being worked out.
Production of “Treatment” will move from L.A. to Gotham when lensing begins again in the fall. Shift was influenced in part by the fact that Byrne lives in New York, as well as by the lure of New York’s new city and state tax incentives for film and TV productions.
Series has also added an exec producer-showrunner in Warren Leight, a Gotham-based playwright who has spent the past few seasons as exec producer of NBC/USA Network’s “Law & Order: Criminal Intent.”
Also returning as exec producers are Rodrigo Garcia, who developed the U.S. adaptation; Stephen Levinson and Mark Wahlberg, whose Leverage production shingle produces HBO’s “Entourage”; and Hagai Levi, creator of the original Israeli series.